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Monitoring programs have traditionally monitored legacy contaminants but are shifting
focus to Contaminants of Emerging Concern (CECs). CECs present many challenges
for monitoring and assessment, because measurement methods don’t always exist
nor have toxicological studies been fully conducted to place results in proper context.
Also some CECs affect metabolic pathways to produce adverse outcomes that are not
assessed through traditional toxicological evaluations. Antibiotics are CECs that pose
significant environmental risks including development of both toxic effects at high doses
and antibiotic resistance at doses well below the Minimum Inhibitory Concentration (MIC)
which kill bacteria and have been found in nearly half of all sites monitored in the US.
Antimicrobial resistance has generally been attributed to the use of antibiotics in medicine
for humans and livestock as well as aquaculture operations. The objective of this study
was to assess the extent and magnitude of antibiotics in the environment and estimate
their potential hazards in the environment. Antibiotics concentrations were measured in
a number of monitoring studies which included Waste Water Treatment Plants (WWTP)
effluent, surface waters, sediments, and biota. A number of studies reported levels of
Antibiotic Resistant Microbes (ARM) in surface waters and some studies found specific
ARM genes (e.g., the blaM−1 gene) in E. coli which may pose additional environmental
risk. High levels of this gene were found to surviveWWTP disinfection and accumulated in
sediment at levels 100–1000 times higher than in the sewerage effluent, posing potential
risks for gene transfer to other bacteria.in aquatic and marine ecosystems. Antibiotic risk
assessment approaches were developed based on the use of MICs andMIC Ratios [High
(Antibiotic Resistant)/Low (Antibiotic Sensitive) MIC] for each antibiotic indicating the
range of bacterial adaptability to each antibiotic to help define the No Observable Effect
Concentration (NOEC) for each antibiotic which were compared to maximum Measured
Exposure Concentrations (MEC) in the environment to predict individual environmental
risks. Four antibiotics had high MEC/NOEC and high MIC ratios and were identified as
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higher risks for concern based upon this approach, but only Triclosan had MEC/NOEC
ratios >1 and was recommended for monitoring in future studies.
Keywords: contaminants of emerging concern, antibiotics, no observable effects concentration, maximum
exposure concentration, blaM−1 genes
INTRODUCTION
Antimicrobials are pharmaceutical drugs developed to target
and combat biological infections, such as those occurring
from bacteria, fungi, viruses, and protozoans. Among the
antimicrobials, antibiotics are most often defined as any
chemotherapeutic agent capable of inhibiting or killing bacteria
(bacteriostatic or bactericidal). While compounds with these
properties have been used for centuries, it was not until the
late 1920s that the first antibiotic was isolated (Van Epps and
Dubos, 2006). Since this initial discovery, the use and production
of antibiotics has continued to increase yearly. Wise (2002)
estimated that between 1 and 2 × 108 kg of antibiotics are
consumed annually worldwide. The estimated percentages vary
between countries and availability of information for most of
the developing countries is scarce. For instance, in the European
Union (EU), Switzerland, and the US, the usage is estimated to
be 50% for human and 50% for veterinary medicine (Kummerer,
2009). A more recent estimate for the US released by the FDA
in 2010, indicates that 1.3 × 107 kg of antibiotics (∼60%) are
used for agricultural purposes, including aquaculture, while the
remaining 40% are used for human clinical use (U.S. Food Drug
Administration., 2010). Globally, the annual consumption of
antibiotics is estimated in 70 billion standard units for human
use (Van Boeckel et al., 2014) and 63,151 ± 1560 tons/year for
livestock (Van Boeckel et al., 2015). Within 15 years, both figures
are expected to increase by 30 and 67% for human and veterinary
purposes, respectively (Gelbrand et al., 2015).
When antibiotics were first introduced, Alexander Fleming,
who won a Nobel Prize for the discovery of penicillin, warned
in 1945 that misuse of the drug could result in selection for
resistant bacteria (Rosenblatt-Farrell, 2009). Within 10 years of
the wide-scale introduction of penicillin, antibiotic resistance to
this drug was observed. Although antibiotics have transformed
the treatment of biological infections and greatly reduced the
duration of infections and associated morbidity and mortality,
the over-prescription and misuse of these drugs in medicine and
agriculture have resulted in an increased rate of development
and propagation of resistantmicrobial populations. This problem
is considered so significant that many experts suggest the value
of existing antibiotic therapies over the next 100 years is now
uncertain (Rosenblatt-Farrell, 2009). Consumption of antibiotics
in human medicine rose by nearly 40% overall between 2000
and 2010, but actual global usage patterns are more complex
with decreases occurring in some countries and rapid increases
Abbreviations: CECs, Contaminants of Emerging Concern; ARM, Antibiotic
Resistant Microbes; CAFOs, Confined Animal Feeding Operations; MEC,
Maximum Exposure Concentration; MICs, Minimum Inhibitory Concentration;
LOEC, Lowest Observable Effect Concentration; NOEC, No Observable Effect
Concentration; WWTP, Waste Water Treatment Plant.
in others (O’Neill, 2014). The emerging economic countries of
the world plus South Africa accounted for three quarters of
this growth, while annual per-person consumption of antibiotics
varies by more than a factor of 10 across all middle and high-
income countries (Van Boeckel et al., 2014). Furthermore, the
European Centre for Disease Control (2013) monitored 15
European countries and found that more than 10% of people
in these areas contained Staphylococcus aureus bloodstream
infections which were methicillin-resistant (MRSA), with several
of these countries demonstrating resistance rates approaching
50%. Currently, mortality rate attributable to antimicrobial
resistance represent 700,000 deaths every year (O’Neill, 2014).
These figures have been estimated to increase up to 10 million
deaths/year by 2050, with antimicrobial resistance becoming
“one of” the leading cause of death in the world if greater control
measures and policies are not implemented (O’Neill, 2014).
The observed increased rate of antibiotic resistance in bacteria
is likely due many complex factors that ultimately drive the
development and maintenance of direct and indirect methods
of microbial resistance. Chemicals with antimicrobial properties
may naturally occur in the environment where they provide
selective pressure for maintenance of antimicrobial resistance
within certain microbes. This natural intrinsic resistance occurs
in some bacteria as a result of the over-expression of genes
involved in regulating cellular permeability to hydrophobic
compounds, such as macrolide antibiotics (Rosenblatt-Farrell,
2009). In addition, some microbes may temporarily overexpress
or suppress a range of genes allowing survival in the presence of
naturally occurring chemicals, with expression patterns returning
to normal once the exposure threat has passed. As a result,
many microbes have “Intrinsic Resistance” to natural chemicals
or antibiotics when their normal metabolic or physiological
characteristics are changed to render them immune to the
mechanism of effect associated with specific types of chemical
exposure (Humeniuk et al., 2002).
While antibiotic resistancemay occur naturally, the additional
input of exogenous chemicals, with antimicrobial properties
from anthropogenic sources, may provide increased selective
pressure for the generation and propagation of resistant
phenotypes within microbial communities (Rosenblatt-Farrell,
2009). Certain microbes may also have “Acquired Resistance”
to an antibiotic by taking on new adaptive characteristics
either through gene mutation or the transfer of genetic
material between bacteria (Rosenblatt-Farrell, 2009). Thus, once
exposed to antibiotics, resistant phenotypes may arise through a
combination of intrinsic, mutational, or acquired mechanisms.
Acquired resistance enables microbes to become more resistant
to antibiotics and examples may include changes to the bacterial
membrane such as increased activity of multidrug resistance
(MDRs) proteins, which prevent antibiotics from entering the
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cell. Microbes may also use enzymes to break down antibiotics, or
they may employ “eﬄux pumps” to remove the antibiotic entirely
or reduce its concentration below effective levels (Rosenblatt-
Farrell, 2009).
Thus, resistant phenotypes may arise through random
mutational events that result in protein target site modification,
changes in cell wall structure, and altered metabolic pathways.
One of the greatest contributing factors to increased rates of
global antibiotic resistance is the ability of these resistant traits
to be rapidly transferred through mobile elements both vertically
and horizontally through microbial communities resulting in
widespread acquired resistance. Once these resistance traits are
generated or acquired, they are capable of beingmaintained long-
term even in the absence of antibiotics through reduced gene
expression, storage within integron systems, and non-antibiotic
co-selection pressure. Clearly antibiotics and the attending
problems of antibiotic resistance inmicrobes result in this class of
chemicals having unique environmental hazards and risks within
the different types of Contaminants of Emerging Concern (CECs)
currently being assessed.
The objectives of this review were to evaluate the occurrence
of antibiotics, as both CECs and antibiotic resistant pathogens
within the environment and to evaluate approaches developed to
potentially assess and predict antibiotic resistance risks within the
environment.
MATERIALS AND METHODS EMPLOYED
IN THIS REVIEW
Literature reviews of existing studies measuring the occurrence of
antibiotics, antibiotic resistant microbes (ARM) andmechanisms
of antibiotic resistance in aquatic environments were conducted.
Concentrations of antibiotics measured in surface waters,
sediments and biota from peer reviewed published studies and
government reports were compiled and summarized, drawing
very heavily on two recent reports conducted by the Water
Environment Research Foundation for freshwater (Diamond,
2011) and the Southern California Coastal Water Research
Project for estuarine, coastal, and marine waters (Anderson
et al., 2012) which compiled data on exposure and effects of
antibiotics in the environment. Similarly, levels of antibiotic
resistance within E. coli and other indicator bacterial species
were summarized and reported from selected studies conducted
in different coastal locations around the U.S. Both government
reports and peer reviewed literature sources used in these
assessments (U.S. Food and Drug Administration (FDA), 2015).
To assess the range of resistance potential for each antibiotic,
the ratio of the Minimum Inhibitory Concentration (MIC) for
naïve (non-resistant) vs. highly resistant bacteria was compared
between 10 antibiotics (Ampicillin, Ciprofloxin, Azithromycin,
Clarithromycin, Erythromycin, Tetracycline, Sulfathiazole,
Suylfamethoxazole, Sulfamethizole, and Trimethoprim) and
two antibacterial agents (Triclocarban and Triclosan) found
frequently in monitoring studies throughout the U.S (Diamond,
2011; Anderson et al., 2012). Anderson et al. (2012) also
assessed the risk posed by antibiotics within the environment,
by using the lowest reported MIC for each antibiotic as a No
Observable Effects Concentration (NOEC = most sensitive
bacteria) which was then compared to the maximum Measured
Exposure Concentration (MEC) reported for each antibiotic.
The MEC/NOEC ratios were then reported for the 10 antibiotics
and two antimicrobial agents assessed. Those which exceeded
unity (>1) were considered a significant risk (Anderson et al.,
2012). Margins of Safety (1 divided by the MEC/NOEC Ratio for
each antibiotic) were also calculated using results from Anderson
et al. (2012) to indicate relative differences in safety between
different antibiotics. Finally, MIC Ratios [Highest Inhibitory
Concentration (e.g., most resistant strain) divided by the Lowest
Inhibitory Concentration (e.g., most sensitive strain)] were
calculated as suggested by Anderson et al. (2012) to provide an
estimate of the relative potential to develop antibiotic resistance.
Statistical analysis included general descriptive statistics (e.g.,
calculation of mean, range, sample size) for compiled or
summarized data. Any rigorous statistical comparisons were
derived directly from results cited within each individual article
cited. One exception was the tidally adjusted estimated rates of
antibiotic resistance in E. coli (e.g., Table 5) made by dividing
the reported rate of resistance by a tidal range ratio between
locations (e.g., ratio of mean spring tidal range for Charleston,
SC in comparison to mean tidal ranges at other locations in
Maryland and Florida).
ANTIBIOTIC LEVELS MEASURED IN THE
ENVIRONMENT
National monitoring programs have identified detectable levels
of select antibiotics in 48% of 139 US surface waters
tested at maximum concentrations ranging from 0.1 to
10 ug/L [U.S. Geological Survey (USGS), 2002], indicating
the widespread use and discharge of these compounds into
the environment. Kolpin et al. (2002) as part of this USGS
study reported that nation-wide a total of 14 antibiotics
(Chlortetracycline, Ciprofloxacin, Erythromycin, Lincomycin,
Norfloxacin, Oxytertracycline, Roxithromycin, Sulfamethoxine,
Sulfamethazine, Sulfamethizole, Sulfamethoxazole, Tetracycline,
Trimethoprim, and Tylosin) were detected by the USGS, with
the frequency of detection for individual antibiotics ranging
from 0.9 to 27.4% and median concentrations ranging from
0.02 to 0.42 ug/L. The five most frequently detected antibiotics
were Tylosin (13.5%), Lincomycin (19.2%), Sulfamethexoazole
(19.5%), Erythromycin (21%), and Trimethoprim (27.5%)
(Kolpin et al., 2002). Frequently measured antibiotics in other
studies of US coastal surface waters include Erythromycin,
Trimethoprim and Sulfamethoxazole (Pait et al., 2006; Benotti
and Brownawell, 2007). For example, in surface waters of
Jamaica Bay in NY, Benotti and Brownawell (2007) found
levels of Trimethoprim and Sulfamethoxazole in eﬄuent
ranging from 130 to 240 and 70 to 140 ng/L, respectively
vs. levels in surface waters ranging from 1 to 42 and 1
to 26 ng/L, respectively (Table 1). In addition, surface water
concentrations of both Trimethoprim and Sulfamethoxazole
decreased rapidly with increasing salinities and distance
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TABLE 1 | Comparison of antibiotics of concern detected in different
regions of the US.
Location Antibiotics of concern
SC effluenta,b,c Triclosan, Tetracyclines (COT), Ampicillin,
Penicillin
Chesapeake bay effluentd Erythromycin, Sulfamethoxale,
Trimethoprim
NY WWTP effluente Sulfamethoxazole and Trimethoprim
Southern CA WWTP effluentf,g,h,i Azithromycin, Trimethoprim, Triclosan
Southern CA inshore: watersf,g,h,i Sulfamethoxazole, Clarithromycin
Sulfamethizole, Trimethoprim
Southern CA inshore: sedimentsf,h,i Azithromycin, Ciproflaxin, Erythromycin,
Triclocarban, Sulfamethoxazole,
Trimethoprim
Southern CA offshore: sedimentf,h,i Azithromycin, Trimethoprim
Southern CA Musselsf,h,i Sulfamethiazole, Erythromycin,
Triclocarban
CA and Montana septic tanksj,k Erythromycin, Sulfamethoxazole,
Sulfathiazole, Trimethoprim
References cited: aNational Oceanic and Atmospheric Administration (2011);
bHedgespeth et al. (2012); cFerry (2015); dPait et al. (2006); eBenotti and Brownawell
(2007); fAnderson et al. (2012); gDiamond (2011); hKlosterhaus (2010); iKlosterhaus
et al. (2013); jGodfrey et al. (2007); kSan Diego Regional Water Quality Board. (2011).
downstream from sewerage outfall and also during heavy rainfall,
as concentrations of both antibiotics declined significantly due
to the increased dilution effects observed with increased surface
runoff (Benotti and Brownawell, 2007). Godfrey et al. (2007) and
the San Diego Regional Water Quality Board. (2011) similarly
reported Erythromycin, Sulfamethoxazole, Sulfamethoxazole
and Trimethoprim in septic tank eﬄuent in Montana and
California.
In Southern California (Klosterhaus, 2010; Diamond, 2011;
Klosterhaus et al., 2013), antibiotics detected in surface
waters included Clarithromycin (Mean 5 ng/L; Max 18 ng/L),
Erythromycin (Mean 4 ng/L; Max 12 ng/L), Sulfamethizole
(Mean 3 ng/L; Max 16 ng/L), and Trimethoprim (Mean 1 ng/L;
Max 4 ng/L) (Table 1; Figure 1). In Southern California estuarine
sediments, several antibiotics were detected and measured
including Ciprofloxacin (Mean 480 ng/g dry weight (dw); Max
600 ng/g dw), Erythromycin (Mean 1 ng/g dw; Max 3 ng/g
dw), Sulfamethoxazole (Mean 0.1 ng/g dw; Max 1 ng/g dw),
Triclocarban (8 ng/g dw and 33 ng/g dw), and Trimethoprim
(Mean 3 ng/g dw; Max 18 ng/g dw). In Southern California
Bight and other offshore sediments, antibiotics detected included
Azithromycin (Mean 2.95 ng/g dw; Max 19.884 ng/g dw)
and Trimethoprim (Mean 0.35 ng/g dw; Max 0.581 ng/g dw).
In Southern California wastewater treatment plant (WWTP)
offshore outfalls, several antibiotics were detected and measured
including Azithromycin (Mean 1.31 ng/g dw; Max 10.72 ng/g
dw) and Trimethoprim (Mean 0.30 ng/g dw; Max 0.49 ng/g
dw). In Southern California mussels, antibiotics detected
and measured included Erythromycin (Mean 0.1 ng/g ww;
Max 0.2 ng/g ww), Sulfamethiazole (Mean 0.04 ng/g ww; Max
0.2 ng/g ww), and Triclocarban (0.5 ng/g ww and 2.0 ng/g ww)
(Table 1; Figure 1).
FIGURE 1 | Antibiotic concentrations measured in different
environmental compartments of coastal ecosystems of southern
California.
TABLE 2 | Mechanism of action for antibiotics in causing microbial
resistance (modified after Romero et al., 2012).
Mode of action Class of antibiotics causing effects
Interference with cell wall synthesis beta-Lactams and Glycopeptides (e.g.,
Penicillins, Cephalosporins, Carbapenems,
and Vancomycin)
Inhibition of metabolic pathways Sulfonamides, Trimethoprim, Folic Acid
analogs
Protein synthesis inhibitors Macrolides, Chloramphenicol, Clindamycin,
Linezolid, Aminoglycosides, Tetracyclines
Interference with nucleic acid
(DNA/RNA) synthesis
Mupirocin, Fluorquinolones, Rifampin
Disruption of bacterial membrane
structure
Polymyxins and Daptomycin
ANTIMICROBIAL RESISTANCE
The term antimicrobial resistance has been broadly defined
as the development of adaptive physiological responses to all
pharmaceuticals used to kill or inhibit the growth of pathogenic
microorganisms (bacteria, viruses, fungi, and protozoa) and
include antibiotics (antibacterials), antifungals, antivirals, and
antiparasitics drugs. Antibiotic resistance may involve both
physiological/metabolic and genetic, molecular adaptation by
microbes in response to antibiotic mode of action and may
involve several major adaptive responses (Table 2). These
may include changes in the cell wall, metabolism, proteins
or nucleic acids (DNA or RNA) and bacterial membrane
structure (Romero et al., 2012). Cell wall inhibition is perhaps
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the most widespread response observed among microbes by
which antibiotics (beta-Lactams and Glycopeptides) kill bacteria
by damaging or inhibiting the cell wall synthesis (Romero
et al., 2012). Other antibiotics may affect microbes by (1)
affecting bacterial metabolism, such as trimethoprim and the
sulfonamides; (2) by affecting DNA or RNA synthesis, such as
quinolones and rifampin; or (3) by affecting protein synthesis,
such as chloramphenicol, the tetracyclines, the aminoglycocides,
and the macrolide antibiotics.
The spread of antimicrobial resistance has generally been
attributed in part to: (1) prescriptive drug use by people and
animals given therapeutic doses in medical and agricultural
practices; (2) environmental release from waste treatment and
disposal activities that concentrate animal, medical and human
wastes such as WWTPs [Federal Interagency Working Group
– Pharmaceuticals in the Environment (FIWG-PIE), 2009],
municipal land fields (Wintgens et al., 2003; Barnes et al.,
2004; Slack et al., 2005) and confined farm animal practices;
and (3) aquaculture practices that use these drugs directly
administered to fish and shellfish (primarily in feeds) within
aquatic environments [Federal Interagency Working Group
– Pharmaceuticals in the Environment (FIWG-PIE), 2009;
Uyaguari et al., 2010]. Most antibiotics however are compounds
produced by bacteria and fungi in the environment, providing
a natural source of selection and maintenance of antibiotic
resistant phenotypes even in the most pristine environments
(Davies and Davies, 2010). For example, the β-lactamase genes
are ancient (Barlow andHall, 2002), having been found in remote
and desolate environments such as Alaska (Allen et al., 2009),
which suggests that novel β-lactamases with altered substrate
ranges occur throughout the environment (Aminov, 2009; Davies
and Davies, 2010). Similarly, antibiotic resistance has also been
found in minimally-impacted marine environments, such as
National Estuarine Research Reserves such as North Inlet and the
ACE Basin in South Carolina (Kelsey et al., 2003a,b; Thompson,
2007; Baker-Austin et al., 2008; Uyaguari et al., 2011).
With naturally occurring antibiotic resistance prevalent in the
environment along with the widespread occurrence of antibiotics
in U.S. surface waters (e.g., 48% of 139 US surface waters) (U.S.
Geological Survey (USGS), 2002), it is not surprising to findARM
within the environment.While, Davies and Davies (2010) suggest
that antibiotic resistance has increased since the 1960s, Aminov
(2009) suggest that it is difficult to explain the role of antibiotics
and antibiotic resistance in natural environments from an
anthropocentric point of view per se. Several regional studies
(Kaspar et al., 1990; Parveen et al., 1997; Van Dolah et al., 2000;
Webster et al., 2004; Thompson, 2007; National Oceanic and
Atmospheric Administration, 2011) have surveyed WWTPs and
confined animal feeding operations (CAFOs), where antibiotics
are often discharged into the environment primarily from human
use and are frequently used in livestock production, respectively.
Results from monitoring of sites throughout mid-Atlantic and
southeastern US have found the rate for detection of multiple
antibiotic resistance E. coli bacteria ranged from 5 to 22% in
WWTPs and from 12 to 16% in farm animal operations (chicken
and hog farms) (Tables 3, 4). The number of antibiotics to
which multiple antibiotic resistance was observed ranged from
TABLE 3 | Impaired Watershed Study in South Carolina (SC) (National
Oceanic and Atmospheric Administration, 2011).
Source MAR indexa Antibiotics detectedb
WWTPs 8 COT
Chicken farms 16 COT
Hog farms 12 COT
SC IMPAIRED WATERS
Savannah river 2.9 PCKNOSSfT
Catawba river 0.9 APOT
Saluda river 2.8 APT
Pee Dee river 2.0 AP
Waccamaw river 3.9 APOT
MAR Index indicates the percentage of antibiotic resistant E. coli bacterial isolates. The
Antibiotics Detected indicate the specific antibiotics which E. coli isolates expressed
resistance to. The dominant patterns of resistance were to three different Tetracyclines
(Disruption of Protein Synthesis) in WWTPs, chicken farms, and hog farms. In surface
waters, generally antibiotic resistance to the Tetracyclines (Disruption of Protein Synthesis)
was observed along with resistance to Penicillin and Ampicillin (Cell Wall Inhibitors) was
observed in each bacterially impaired watershed.
aMultiple Antibiotic Resistance Index (MAR) = Number of Resistant Isolates/Total Isolates
× 100.
bAntibiotics Tested: Ampicillin (A), Chlortetracycline (C), Kanamycin (K), Nalidixic Acid
(N), Neomycin (Ne), Oxytetracycline (O), Penicillin (P), Streptomycin (S), Sulfathiazole (Sf),
Tetracycline (T).
1 to 8 antibiotics, averaging 4.6 antibiotics/WWTP [Webster
et al., 2004; Thompson, 2007; National Oceanic and Atmospheric
Administration, 2011]. Figure 2 depicts the mechanism by which
antibiotic resistance can occur as antibiotics may kill sensitive
bacterial strains/biotypes lowering MICs, leaving more resistant
strains to persist which will have much higher MICs.
Once developed, the maintenance and spread of antibiotic
resistant phenotypes becomes a secondary issue within the
environment, including aquatic environments [Federal
Interagency Working Group – Pharmaceuticals in the
Environment (FIWG-PIE), 2009; Uyaguari, 2011; Uyaguari
et al., 2011]. Monitoring of marine surface waters in various
regions of the U.S. has indicated rates of antibiotic resistance
vary based upon tidal range, which may dilute the microbial
source, and land use activity (urban vs. rural), with urban areas
generally having 2–3 times higher levels of antibiotic resistance
observed than rural areas (Table 5). Levels of antibiotic resistant
E. coli bacteria ranged from 13 to 25% in FL (microtidal –
<1 m), 2.6–9% (mesotidal – >1 – < 2 m) in MD and from 1
to 3% in SC (mesotidal – >2 – <3 m) coastal waters. When
adjusted for tidal range differences, the rates of antibiotic
resistance were quite similar (Table 5) in both urban and rural
areas underscoring the importance of dilution in affecting the
magnitude of antibiotic resistance detected. Environmental
realistic exposures from these sources generally result in
pharmaceutical exposure concentrations that are much lower
than therapeutic doses; however, uncertainty exists about the
potential for biologically meaningful human and ecological
effects from chronic exposures to low concentrations and
mixtures of these compounds, especially in the environment
and in subpopulations of humans and wildlife that might be
particularly sensitive (Pomati et al., 2006, 2008).
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TABLE 4 | Rates of antibiotic resistance in E. coli from selected US
Watersheds.
Watershed Effects measured References
RATES OF MICROBIAL ANTIBIOTIC RESISTANCE
MD (Ches. Bay)a MARb E. coli = 2.8–9% in
marine waters
Kaspar et al., 1990
FL MARb E. coli = 13–25% in
marine waters
Parveen et al., 1997
SCc MARb E. coli = 0.9–3.9% in
freshwater & coastal waters
National Oceanic and
Atmospheric
Administration, 2011
SCd MARb E. coli = 1–3% in coastal
waters
Van Dolah et al., 2000
SC STPs MARb E. coli = 5–22% in effluent Webster et al., 2004
SC CAFOs MARb E. coli = 12–16% in
effluent
National Oceanic and
Atmospheric
Administration, 2011
SC Dolphinse MARb E. coli measured in 39%
of dolphins (resistance to
Ampicillin, Amoxicillin,
Cephalothin, and Penicllin)
Greig et al., 2007
FL Dolphinsf MARb E. coli measured in 8% of
dolphins
Greig et al., 2007
DETECTABLE LEVELS OF ANTIBIOTICS IN SURFACE WATERS OR
POLLUTION SOURCES
US Watershedsg 48% of the sites had detectable
levels of Antibiotics
U.S. Geological Survey
(USGS), 2002
SC Golf Courses 1–63 ng/L Oxytetracycline
measured in WWTPs and effluent
used for golf course irrigation
National Oceanic and
Atmospheric
Administration, 2011
aMD Chesapeake Bay watersheds included Anacostia R., Annapolis Harbor, Baltimore
Harbor, Chester River, Miles River, Wye River, and Love Point.
bMAR is Multiple Antibiotic Resistance = Number of Microbial Resistant Isolates/Total
Number of Isolates.
c Impaired watersheds of SC (Catawba, Pee Dee Saluda, Savannah, and Waccamaw
Rivers).
dBroad Creek and Okatee River Watersheds.
eCharleston Harbor Dolphins.
f Indian River Lagoon Dolphins.
g139 Watersheds Nationwide in the US.
ANTIBIOTIC RESISTANCE GENES
Bacteria can become resistant to antibiotics through a series
of mechanisms [e.g., permeability changes in cell wall or
eﬄux of antimicrobials from the bacterial cell (Van Hoek
et al., 2011)]. This resistance is initially gained through
evolutionary mechanisms wherein exposures to either natural
or anthropogenic sources of antibiotics (or other co-selective
factors) activate a bacterial stress response resulting in gene
mutations that subsequently undergo positive selection. Thus,
while it true that some antibiotics increase the mutation rate
and may subsequently increase the chances of getting the
right mutation causing antibiotic resistance, antibiotic resistant
bacteria with mutant genes do not necessarily require subsequent
acquisition of other resistance genes in order to develop
resistance. In this context, recent studies have demonstrated
that conventional wastewater treatment does not necessarily
reduce the number of known antibiotic resistance genes within
the overall gene pool (Auerbach et al., 2007; Uyaguari, 2011;
Uyaguari et al., 2011). Thus, WWTPs may play a very important
role as a reservoir of pre-existing resistance genes, generator
of novel bacterial resistance, or vehicles for the adaptation of
microbes. Interestingly, the level of antibiotic resistance within
the gene pool may be higher inWWTP eﬄuent than in pretreated
sewage (Reinthaler et al., 2003; Uyaguari et al., 2011), suggesting
that the treatment process could be further effective in selecting
for more resistant bacteria.
Uyaguari et al. (2011) used a coupled metagenomic and
quantitative PCR approach to discover a novel variant of a gene
conferring resistance to ampicillin (blaM−1), and to show that
this gene is enriched and temporally maintained throughout a
WWTP, suggesting that WWTP processes may provide a long-
term selective environment for resistant bacteria (Figure 3).
Uyaguari et al. (2011) also observed abundances of the blaM−1
gene within surrounding estuarine sediments at abundances
higher than that found in discharged eﬄuent, suggesting
sediments may be providing an environmental reservoir for these
genes (Figure 4). TheWWTP in Charleston, SC examined in this
study discharged an average of 136 million L day-1 of treated
wastewater, which represents on average approximately 3.9 ×
10∧14 gene copies of blaM−1 released daily into the surrounding
ecosystem (Uyaguari et al., 2011).
Evidence suggesting eﬄuent discharges contain antibiotic
resistance conferring genetic material (plasmids, free DNA,
integrons, bacterial genomes) has been well documented
(Tennstedt et al., 2003; Szczepanowski et al., 2004, 2009;
Auerbach et al., 2007; Munir et al., 2011; Uyaguari et al., 2013;
Pellegrini et al., 2011). Bacterial acquisition of genes involved
in these resistance mechanisms is achieved by a variety of
promiscuous gene transfer systems or elements such as bacterial
conjugative plasmids, transposons, and integrons (Bennett, 2008;
Garriss et al., 2009). These elements allow genes to move
vertically and horizontally from one cell to another throughout
microbial communities, regardless of the gene donor and may
in part explain why antibiotic resistance phenotypes are widely
distributed across geographical regions (Bennett, 2008; Zaneveld
et al., 2008). For instance, within marine ecosystems, Baker-
Austin et al. (2008) isolated 350 V. parahaemolyticus strains from
water and sediment at three locations along the Atlantic coast of
Georgia and South Carolina and found that 99% were antibiotic
resistant, with 24% of the isolates demonstrating resistance to
10 or more antibiotics. The average rate of antibiotic resistance
was 7.5 antimicrobials per isolate. Since vibrios are marine
bacteria, the development of antibiotic resistance within these
potential pathogens underscores the importance of antibiotics in
the marine environment and the accompanying propagation of
resistance genes that may be selected resulting from exposure.
Horizontal gene transfer mechanisms may also play a role in
the continued loss of antibiotic effectiveness against a range of
microbes. For example, the antibiotic vancomycin was the first
choice to treat Gram-positive bacterial infections, but use has
declined due to acquired resistance first observed in enterococci
and later documented in the U.S. as a completely resistant strain
in S. aureus (MIC > 16µg/mL) (Ala’Aldeen and Hiramatsu,
2004). Among the different elements of antibiotic resistance
transfer, integrons are considered one of the main agents of
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FIGURE 2 | Mechanisms for development of antibiotic resistance (modified after Rosenblatt-Farrell, 2009). The landscape of antibiotic resistance. Environ
Health Perspect. 117: A244-A250). Top portion of the figure: (1) Most bacteria are antibiotic sensitive (blue) and not resistant (white). (2) Exposure to an antibiotic at or
above the MIC results in mortality (black) in most antibiotic sensitive bacteria. (3) This leaves behind more antibiotic resistant bacteria which will have a higher MIC as a
result. Mechanisms for acquiring ABR are depicted in the bottom part of the figure.
bacterial evolution involved in overall bacterial adaptation to
varying environmental conditions and likely play a role in
widespread dissemination of antibiotic resistance genes (Mazel,
2006; Joss et al., 2009; Uyaguari et al., 2013).
ASSESSING THE RISKS OF ANTIBIOTICS
Anderson et al. (2012) assessed the risk of 10 antibiotics and
2 antibacterial agents commonly detected in environmental
monitoring studies. For each antibiotic and antibacterial agent,
a range of MICs measured in E. coli and other indicator bacteria
were determined based upon a review of peer reviewed scientific
literature. The Lowest Concentration Causing Resistance (LCCR)
for reported MICs was determined for each antibiotic and
antibacterial agent and was used as a LOEC for risk assessment.
The NOEC was a concentration <LOEC. Risk of effects for ABR
was determined by comparing the MEC and NOEC ratio for
each antibiotic and antibacterial agent. When the MEC/NOEC
>1 excess risks were predicted. Also, the ratio between the
highest and lowest MICs was also used as a metric predicting
the vigor (potency) of antibiotic resistance for each antibiotic
and antibacterial agent and was also considered in addition to
MEC/NOEC Ratio. Any MEC/NOEC Ratio > 1 would indicate
that antibiotic concentrations in the environment exceed NOEC
levels and may pose risk to the environment. Also a Margin
of Safety for each antibiotic/antibacterial agent was calculated
by taking a MEC/NOEC Ratio of 1 (where excess risks occur)
divided the MEC/NOEC Ratio for each antibiotic/antibacterial
agent.
Results indicated (Tables 6, 7):
(1) Ampicillin (CAS number 69-53-4)—Ampicillin is a cell
wall inhibitor class of antibiotic. The MICs ranged from 8000 to
32,000 ug/L and the LCCR was 1000 ug/L which was used as a
LOEC. The NOEC was estimated to be <1000 ug/L. The MEC
was <0.10 ug/L. The MEC/NOEC ratio was <0.0001. The ratio
between the highest MIC and LCCR was 32 (32,000/1000 ug/L)
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TABLE 5 | Comparison of antibiotic resistance in E. coli bacteria at
different coastal geographical locations in Maryland, South Carolina, and
Florida.
Watershed Site MARA,1 % Difference
Urban vs.
Rural
References
Urban Rural
Florida (Appalachicola
Bay)
25 (3.5) 13 (1.9) 47 Parveen et al.,
1997
Maryland (Anacostia River,
Annapolis Harbor, and
Baltimore Harbor vs. Love
Point and Chester, Miles,
and Wye River)
9.0 (4.5) 2.8 (1.4) 69 Kaspar et al.,
1990
South Carolina (Broad
Creek and Okatee River)
3.0 1.0 67 Van Dolah et al.,
2000
Note that the levels of Antibiotic Resistant Bacteria is 47–69% higher in urban watersheds
than in rural watersheds. While absolute rates of MAR differ between locations, but when
adjusted for differences in tidal range between locations were quite similar.
AMAR, Multiple Antibiotic Resistance (# of Antibiotic Resistant Isolates/Total # of
Isolates × 100).
1Values in parenthesis indicate MAR Levels that are tidally adjusted for a 7 foot tidal range
in SC compared to the tidal range for MD and FL sites.
FIGURE 3 | The blaM−1 gene levels in WWTP effluent from SC (modified
after Uyaguari et al., 2011, Appl. Environ. Microbiol. 77: 8226–8233).
Note the much higher blaM−1 gene levels in the final effluent than in the raw
sewerage or sludge, when normalized to DNA. Upper and lower case letters
(A,B, a, and b) indicate difference in levels of blaM−1 genes across different
WWTP stages of treatment for years 2007 and 2009, respectively.
which is indicative of the range of resistance for bacterial
response to this antibiotic. The Margin of Safety was ≤10,000.
(2) Ciprofloxacin (CASnumber 87521-33-1)—Ciprofloxacin
is an inhibitor of DNA replication. The MICs ranged from 1000
to <4000 ug/L and the LCCR was 60 ug/L, which was used as
a LOEC. The NOEC was estimated to be <60 ug/L. The MEC
was 0.182 ug/L. The MEC/NOEC ratio was <0.003. The ratio
between the highest MIC and LCCRwas 67 (4000/60 ug/L) which
is indicative of the range of resistance for bacterial response to
this antibiotic. The Margin of Safety was ≤333.
(3) Azithromycin (CAS number 83905-01-5)—
Azithromycin is a protein synthesis inhibitor. The MICs
ranged from 4000 to <8000 ug/L and the LCCR was 250 ug/L
which was a MIC for the most sensitive microbial species,
which was used as a LOEC. The NOEC was estimated to be
<250 ug/L. The MEC was 1.65 ug/L. The MEC/NOEC ratio
was <0.0067. The ratio between the highest MIC and LCCR
was 32 (8000 ug/L/250 ug/L) which is indicative of the range of
resistance for bacterial response to this antibiotic. The Margin of
Safety was ≤149.
(4) Clarithromycin (CAS number 81103-11-9)—
Clarithromycin is a protein synthesis inhibitor. TheMICs ranged
from 2000 to 8000 ug/L and the LCCR was 250 ug/L which was
a MIC for the most sensitive microbial species that was used as
a LOEC. The NOEC was estimated to be <250 ug/L. The MEC
was 0.611 ug/L. The MEC/NOEC ratio was <0.0024. The ratio
between the highest MIC and LCCR was 32 (8000/250 ug/L)
which is indicative of the range of resistance for bacterial
response to this antibiotic. The Margin of Safety was ≤417.
(5) Erythromycin (CAS number 114-07-8)—Erythromycin
is a protein synthesis inhibitor. The MICs ranged from 8000 to
32,000 ug/L and no LCCR was reported. The MIC for the most
sensitive species of 8000 ug/L was used as a LOEC. The NOEC
was estimated to be <8000 ug/L. The MEC was 5700 ug/L. The
MEC/NOEC ratio was <0.00071. The ratio between the highest
and lowest MIC and LCCR was 4 (32,000/8000 ug/L) which
is indicative of an acute chronic ratio for bacterial response to
this antibiotic and was multiplied by 100 (since no LCCR, no
most sensitive MIC value was reported, and there was no other
sublethal parameter endpoint observed) to derive a Safety Factor
of 400 for this antibiotic. The Margin of Safety was ≤1409.
(6) Tetracycline (CAS number 60-54-8)—Tetracycline is a
protein synthesis inhibitor. The MICs ranged from 8000 to
16,000 ug/L and an LCCR of 10 ug/L was reported. The LCCR
for the most sensitive species of 10 ug/L was used as a LOEC. The
NOEC was estimated to be <10 ug/L. The MEC was 1.500 ug/L.
The MEC/NOEC ratio was <0.15. The ratio between the highest
and lowest MIC and LCCR was 1600 (16,000/10 ug/L) which is
indicative of the range of resistance for bacterial response to this
antibiotic. The Margin of Safety was ≤6.7.
(7) Sulfathiazole (CAS number 72-14-0)—Sulfathiazole is a
nucleotide synthesis inhibitor. The MICs ranged from >500,000
to 500,000 ug/L and an LCCR of 250 ug/L was reported. The
LCCR reported for the most sensitive species of 250 ug/L was
used as a LOEC. The NOEC was estimated to be <250 ug/L. The
MEC was 0.200 ug/L. The MEC/NOEC ratio was <0.0008. The
ratio between the highest and lowest MIC and LCCR was 2000
(500,000/250 ug/L) which is indicative of the range of resistance
for bacterial response to this antibiotic. The Margin of Safety was
≤1250.
(8) Sulfamethoxazole (CAS number 723-46-6)—
Sulfamethoxazole is a nucleotide synthesis inhibitor. The
MICs ranged from >76,000 to 76,000 ug/L and no LCCR
was reported. The MIC for the most sensitive species of
76,000 ug/L was used as a LOEC. The NOEC was estimated to be
<76,000 ug/L. The MEC was 2.10 ug/L. The MEC/NOEC ratio
was <0.000028. The ratio between the highest and lowest MIC
was >1 (>76,000/76,000 ug/L) which is indicative of the range of
resistance for bacterial response to this antibiotic. The Margin of
Safety was <35,714.
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FIGURE 4 | The blaM−1 gene levels in the environment (modified after Uyaguari et al., 2011, Appl. Environ. Microbiol. 77: 8226–8233). (A) Sampling sites
in Charleston Harbor and North Inlet, SC. (B) The blaM−1 gene levels measured in sediments at each site. Means with different letters (a–d) indicate statistical
significance at the 0.05 level.
(9) Sulfamethizole (CAS number 144-82-1)—Sulfamethizole
is a nucleotide synthesis inhibitor. The MICs ranged from
512,000 to 128,000 ug/L and no LCCR was reported. The
MIC for the most sensitive species of ranged 32,000–
64,000 ug/L and the lowest Most Sensitive MIC value of
32,000 was used as a LOEC. The NOEC was estimated
to be <32,000 ug/L. The MEC was 0.130 ug/L. The
MEC/NOEC ratio was <0.000004. The ratio between the
highest and lowest MIC was 16 (512,000/32,000 ug/L)
which is indicative of the range of resistance for bacterial
response to this antibiotic. The Margin of Safety was
≤250,000.
(10) Trimethoprim (CAS number 738-70-5)—
Trimethoprim is a nucleotide synthesis inhibitor. The MICs
ranged from >16,000 to 4,000 ug/L and no LCCR was reported.
The lower MIC value reported for the most sensitive species of
4000 ug/L was used as a LOEC. The NOEC was estimated to be
<4000 ug/L. The MEC was 1.288 ug/L. The MEC/NOEC ratio
was <0.000322. The ratio between the highest and lowest MIC
was >4 (>16,000/4000 ug/L) which is indicative of the range of
resistance for bacterial response to this antibiotic. The Margin of
Safety was ≤3106.
(11) Triclocarban (CAS number 101-20-2)—Triclocarban
is an antibacterial agent. The MICs ranged from 80,000 to
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TABLE 6 | MIC and screening level assessment values for 10 antibiotics and two antibacterial agents frequently detected in the environment.
Reference MICaug/ml Lowest observed MIC ug/ml Lowest concentration causing resistance (LCCR) ug/ml NOEC ug/l
CELL WALL INHIBITORS
Ampicillin ≥32 8 1* <1000
DNA/RNA SYNTHESIS INHIBITORS
Ciprofloxacin ≥4 <1 0.06 <60
PROTEIN SYNTHESIS INHIBITORS
Azithromycin >8 4 0.25* most sensitive MIC <250
Clarithromycin 8 2 0.25* highly sensitive MIC <250
Erythromycin ≥32 8 NR <8000
Tetracycline ≥16 8 0.01 <10
METABOLIC INHIBITORS
Sulfathiazole ≥500 10–500 0.25* highly sensitive MIC <250
Sulfamethoxazole Never used as a single drug but always with Trimethoprim
Sulfamethoxazole 76 76 <76,000**
Sulfamethizole 512 128 32–64* <32,000*
Trimethoprim ≥16 4 <4000*
ANTIBACTERIAL AGENT
Triclocarban 80 0.20 0.0001 Microtox LOEC 0.1–200*
Triclosan 200–8000 0.065 0.025* 25
NOECs for antibiotics were based upon use of Highest and Lowest Minimum Inhibitory Concentrations (MICs) estimations derived from literature searches [FDA Website, EPA EcoTox
web site (http://cfpub.epa.gov/ecotox/),1 and google searches] that identified peer reviewed literature sources for indicator bacteria (E. coli) and other bacteria (e.g., Staph aureus) when
MICs for indicator bacteria were not available.
aMIC, Minimum Inhibitory Concentration that prevents bacterial growth; *Indicates LCCR value was based upon most sensitive MIC value.
200 ug/L and an LCCR of 100 ng/L based on a Microtox
LOEC was reported. The lower MIC value reported for the
most sensitive species of 200 ug/L was used as a MIC LOEC
and the Microtox LOEC of 100 ng/l was also reported. The
MIC NOEC was estimated to be <200 ug/L and the Microtox
NOEC was estimated at <0.100 ug/L. The MEC was 0.223 ug/L.
The MEC/NOEC ratios was <0.001 (MIC)–2.23 (Microtox).
The ratio between the highest and lowest MIC was 400
(80,000/200 ug/L) which is indicative the range of resistance for
bacterial response to this antibiotic. The Margin of Safety was
≤1000 based on MICs and 0.45 based on the Microtox EC50
value.
(12) Triclosan (CAS number 3380-34-5)—Triclosan is an
antibacterial agent. The MICs ranged from 65 to 8,000,000 ug/L
and no LCCR was reported. The lowest MIC value reported
for the most sensitive species of 25 ug/L was used as a LOEC.
The NOEC was estimated to be <25 ug/L. The MEC was
2.700 ug/L. The MEC/NOEC ratio was 0.108. The ratio between
the highest and lowest MIC was 320,000 (8,000,000/25 ug/L)
which is indicative of the range of resistance for bacterial
response to this antibiotic. The Margin of Safety was ≤9.26.
This approach provides a risk assessment process for
comparing differences among different antibiotics and
antibacterial agents in terms of overall exposure level in
the environment (MEC), the most sensitive strain (NOEC) and
the range of resistance expressions as determined by the MIC
Ratios. When MECs exceed NOECs there is a clear potential
1(U.S.) Environmental Protection Agency. (2015). EPA EcoTox web site. Available
online at: http://cfpub.epa.gov/ecotox/.
for impacts to the microbial community. The Margin of Safety
estimate provides an indication of how great the potential is
to exceed the MEC/NOEC ratio and allows for consideration
of uncertainty in the quality and quantity of data available
for the evaluation of each antibiotic. There was one antibiotic
(Tetracycline) and one antimicrobial agent (Triclosan) which
had relatively low Margins of Safety ranging from <6.7 to 9.26
using MICs as the estimator for the NOEC. Only one microbial
agent, triclocarban, had an exceedance of the MEC/NOEC
ratio of 1 but only with the use of a Microtox EC50 value
(MEC/NOEC = 2.23) where as MEC/NOEC ratio using the MIC
was only 0.001. Similarly, only two antibiotics—Tetracycline
(High/Low MIC Ratio of 1600) and Sulfathiazole (MIC Ratio
of 2000) and two antimicrobial agents—Triclocarban (MIC
Ratio of 400) and Triclosan (MIC Ratio of 320,000) had large
High/Low MIC Ratios indicating a wide range of response
to differing concentrations of each chemical. For the other
antibiotics the High/Low MIC Ratio ranged from 4 to 67,
indicating a much lower response to differing concentration of
each chemical.
DISCUSSION
As this review has indicated, antibiotics have been detected
in surface waters, sediments, and tissues at many locations
around the US. In the most thorough investigation in surface
waters and freshwater streams by the USGS (Kolpin et al.,
2002), antibiotics and antimicrobial disinfectants were detected
at 22 and 57.6% respectively, of the sites sampled nation-wide
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TABLE 7 | The Maximum Exposure Concentration (MEC), NOEC, MEC, NOEC Ratio, Margin of Safety, and MIC Ratio for 10 commonly detected
antibiotics and two antibacterial agents.
Antibiotic Maximum Exposure Conc. No Observable Effect Conc. MEC/NOEC Ratio Margin of Safetya,b MIC Ratioc
(MEC) (ug/L) (NOEC) (ug/L)
CELL WALL INHIBITORS
Ampicillin <0.10 ≤1000 ≤0.0001 ≤10,000 32
DNA/RNA INHIBITORS
Ciprofloxacin 0.182 ≤60 ≤0.003 ≤333 67
PROTEIN SYNTHESIS INHIBITORS
Azithromycin 0. 337–1.650 ≤250 ≤0.0067 ≤149 32
Clarithromycin 0.611 ≤250 ≤0.0024 ≤417 32
Erythromycin 0.110–5.700 ≤8000 ≤0.00071 ≤1409 4
Tetracycline 1.500* <10 ≤0.15 ≤6.7 1600
METABOLIC INHIBITORS
Sulfathiazole 0.200 ≤250 ≤0.0008 ≤2500 2000
Sulfamethoxazole 2.100 ≤76,000 ≤0.000028 ≤35,714 1
Sulfamethizole 0.130 ≤32,000 ≤0.000004 ≤250,000 16
Trimethoprim 0.180–1.288 ≤4000 ≤0.000322 ≤3106 4
ANTIBACTERIAL AGENT
Triclocarban 0.223 ≤0.1–200 ≤0.001–2.23 ≤1000 (0.45d) 400
Triclosan 0.510–2.700 ≤25 ≤0.108 ≤9.26 320,000
NOECs for antibiotics were based upon use of Highest and Lowest Minimum Inhibitory Concentrations (MICs) estimations derived from literature searches [FDA Website, EPA EcoTox
web site (URL http://cfpub.epa.gov/ecotox/),and google searches] that identified peer reviewed literature sources for indicator bacteria (E. coli) and other bacteria (e.g., Staph aureus)
when MICs for indicator bacteria were not available.
*Chloroxytetracycline.
aAll Margin of Safety values based on MICs.
bMargin of Safety = One divided by the MEC/NOEC Ratio.
cMinimum Inhibitory Concentration (MIC) Ratio = Highest Inhibitory Concentration (most resistant strain)/Lowest Inhibitory Concentration (most sensitive strain).
dMargin of Safety based upon Microtox data and not MIC.
in the US. The most frequently detected antibiotics in
freshwater and eﬄuents included Tetracycline (1.2% frequency
of detection), Chlortetracycline (2.4%), Ciprofloxacin (2.6%),
Sulfamethazine (1.2–4.8%), Roxithromycin (4.8%), Tylosin
(13.5%), Sulfamethoxazole (12.5-19%), Lincomycin (19.2%),
Erythromycin (21.5%), and Trimethoprim (12.4–27.5%), while
Triclosan (57.6%) was the most frequently detected antimicrobial
agent. (Kolpin et al., 2002). Maximum concentrations of these
10 most frequently detected antibiotics ranged from 0.11 to 1.90
ug/L and the maximum concentration for an antimicrobial agent
was Triclosan at 2.70 ug/L (Kolpin et al., 2002). High frequency
of detection and highest maximum concentrations often co-
occurred for both antibiotics (Erythromycin—21% and 1.70
ug/L; Sulfamethoxazole—19% and 1.90 ug/L) and antibacterial
agents (Triclosan—57.6% and 2.70 ug/L).
Results presented in this review of the analyses from
earlier published studies [Benotti and Brownawell, 2007;
Klosterhaus, 2010; Diamond, 2011; National Oceanic and
Atmospheric Administration, 2011; Klosterhaus et al., 2013;
Hedgespeth et al., 2012] similarly indicated the presence
of Ampicillin, Clarithromycin, Erythromycin, Penicillin,
Sulfamethizole, Sulfamethoxazole, Tetracycline, Triclosan,
and Trimethoprim in eﬄuent and marine surface waters of
coastal ecosystems. Similarly in marine sediments Azithromycin,
Ciprofloxacin, Erythromycin, Sulfamethoxazole, Triclocarban,
and Trimethoprim were detected. In mussel tissues (Geukensia
demissa) from California coastal ecosystems, only Erythromycin,
Sulfamethiazole and Triclocarban were detected. These results
clearly indicate that most of the antibiotics reported in coastal
waters in this study were similar to those most frequently
detected antibiotics/antibacterial agents measured in the nation-
wide assessment of eﬄuent and freshwater rivers/streams by
USGS (Kolpin et al., 2002).
Antibiotic resistance was also measured in bacteria within
aquatic environments and may represent a possible general
biomarker of long term antibiotic/antibacterial agent exposure,
although other environmental factors [e.g., temperature
(Hinks et al., 1977; James and Edwards, 1989) and heavy metal
concentrations (Seiler and Berendonk, 2012)] are known to select
antibiotic resistant bacteria. The selected review of published
literature indicated the presence of E. coli which were resistant
to many of the same antibiotics measured in the environment
including Ampicillin, Chlortetracycline, Oxytetracycline,
Penicillin, Sulfathiazole, and Tetracycline in eﬄuent/surface
waters and to Ampicillin and Penicillin in rectal swabs from
bottlenose dolphins [Greig et al., 2007; National Oceanic and
Atmospheric Administration, 2011]. Bacterial resistance was
also observed to Amoxicillin and Cephalothin in rectal swabs
from bottlenose dolphins and to Kanamycin, Nalidixic Acid
and Streptomycin in bacteria in surface waters [Greig et al.,
2007; National Oceanic and Atmospheric Administration,
2011]. Rates of antibiotic resistance ranged from 5 to 22% in
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WWTP eﬄuent, 12–16% in eﬄuent from CAFOs, 0.9–25%
in surface waters, and 8–39% in bottled-nose dolphins [Greig
et al., 2007; National Oceanic and Atmospheric Administration,
2011].
Little is known about the direct connections betweenWWTPs
and antibiotic resistance, yet many characteristics of wastewater
make it a highly suspect medium for the spread of antibiotic
resistance in the environment (Lachmayr et al., 2009). This
includes the presence of antibacterial agents (e.g., Triclosan
and Triclocarban) from household products (hand soaps and
detergents) as well as the presence of antibiotics either excreted
directly by humans or disposed of down the drain in WWTP
waste streams and eﬄuent (Lachmayr et al., 2009). Bacteria
can become resistant to antibiotics naturally through a series
of mechanisms (Aminov, 2009; Davies and Davies, 2010) as
well as resistance conferred by direct exposure to a number of
environmental factors including temperature and heavy metals
(Seiler and Berendonk, 2012), as well as antibiotics. This may
increase the rate of gene mutation and enhance subsequent
acquisition of genes (e.g., coding enzymes that may damage
antibiotics, enzymes that allow synthesis in the presence of
inhibitors, and antibiotic pumps) carried by plasmids or other
mobile genetic elements that may be exchanged with both
naïve and antibiotic resistant bacteria in the environment
(Lachmayr et al., 2009; Uyaguari et al., 2011). Thus, while some
antibiotics may increase the mutation rate and subsequently
increase the chances of causing antibiotic resistance, antibiotic
resistant bacteria with mutant genes do not necessarily require
subsequent acquisition of other resistance genes in order to
develop resistance. Thus, the exact importance of WWTPs
and other major pollutions sources of antibiotic exposure and
genes carried by plasmids or other mobile genetic elements
remain unclear. Results of monitoring antibiotic resistance genes
in a WWTP suggested that the blaM−1 gene, a novel class
A B-lactamase gene conferring resistance to ampicillin was
enriched in the principal eﬄuent which is subsequently released
into the surrounding coastal aquatic ecosystem resulting in
an estimated 3.9 × 1014 copies of the blaM−1 gene released
daily into Charleston Harbor, SC (Uyaguari et al., 2011).
Approximately two-thirds of antibiotics administered to humans
are B-lactams, for which the mechanism of antibiotic resistance
is hydrolysis by B-lactamases (Lachmayr et al., 2009). Lachmayr
et al. (2009) similarly has found that while modern WWTP
technologymay reduce the concentrations of B-Lactam antibiotic
resistance genes, the ratio of the blaTEM genes/16SrRNA genes
increased with treatment, suggesting that bacteria harboring
the blaTEM genes are likely to survive WWTP treatment.
The mobility of these genes is related in part to their
association with transposons and integrons (Lachmayr et al.,
2009).
In coastal environments, Baker-Austin et al. (2008) has
shown that >99% of Vibrio parahaemolyticus isolated from
Charleston Harbor and other sites in coastal South Carolina
and Georgia demonstrate resistance to a range of antibiotics.
Vibrio bacteria are marine bacteria and one of three pathogens
that the CDC reports as showing increased rates of infection,
with most increases in Vibrio infections resulting from wound
infections rather than seafood consumption (Weiss et al.,
2011). The high rates of antibiotic resistance in vibrios
raise concerns about the potential discharge of antibiotic
resistant genes into aquatic environments from WWTPs
and other major pollution sources. As these results and
discussions have clearly shown, the measurement of antibiotic
resistance when measured in combination with chemical
measurements of antibiotics/antibacterial agents as well as
other legacy pollutants that may affect antibiotic resistance
(e.g., heavy metals) will provide important information on
the presence of these CECs within aquatic ecosystems, as
both exposure and possible effects are discerned. While we
acknowledge that there are both naturally occurring levels
of antibiotic resistance and that other environmental factors
may affect antibiotic resistance, such as heavy metals (Seiler
and Berendonk, 2012), direct chemical measurements of
antibiotics concentrations in water and sediments when
coupled with assessment of antibiotic resistance rates in key
indicator bacteria within the environment provide an essential
starting point for environmental assessments. Comparing
the levels and types (genotypes) of antibiotic resistance
in bacteria within the environment throughout a variety
of land use types (pristine, urban, agricultural/livestock)
and pollution sources (e.g., WWTPs, CAFOs) will provide
a better understanding of the significance of antibiotic
exposure within aquatic ecosystems. To be clear however,
these measurements do not indicate risks to humans and the
ecosystems per se.
The use of MICs and resulting risk assessment process
to assess potential effects of antibiotics and antibiotic risk
presented in this study provides a method that can address
both the toxicological hazard of the antibiotic/antimicrobial
agent and also the microbial hazard in terms of development
of antibiotic risks (e.g., plasmids) which may be relevant
to human exposure. MICs represent an estimation of the
concentrations at which adverse effects occur in bacteria and
thus provide a LOEC concentration from which NOECs can
be estimated at levels <LOEC. This derived NOEC can then
be compared to MEC of each antibiotic/antibacterial agent in
the environment to assess whether current levels of antibiotics
in the environment will kill, harm or alter the bacteria. At
MECs >NOECs, mortality in bacteria will occur primarily in
the antibiotic sensitive isolates within the bacterial population,
leaving primarily antibiotic resistant portion of the population
to persist within the environment. These resistant isolates
will have a greater potential to develop plasmid mediated
and other types of resistance. Also antibiotic/antibacterial
agent concentrations < NOEC may also possibly breed
resistance due to the greater potential for sublethal molecular
responses to antibiotic exposure. Those antibiotics/antibacterial
agents, which have had multiple MIC determinations made
at a range of concentrations, have much greater insight
into the potential for development of antibiotic resistance.
This range of MIC determinations may provide a further
estimate of bacterial adaptability to the antibiotic/antibacterial
agent. As bacteria adapt, higher MIC determinations may
be observed which will provide a larger range in MIC
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determinations which may provide a possible estimation of
adaptability differences among different antibiotics and bacterial
species.
The application of our risk assessment methods applied to
10 antibiotics and two antibacterial agents indicated that two
antibiotics Tetracycline and Sulfathiazole and two antibacterial
agents—Triclosan and Triclocarban had highMIC ratios ranging
from 400 to 320,000 compared to MIC ratios ranging from 4
to 67 for the other eight antibiotic assessed. Similarly only one
antibiotic—Tetracycline, and one antibacterial agent—Triclosan,
had high MEC/NOEC ratios (0.108–0.15), low margins of
safety (6.70–9.26) and high MIC ratios (1600–320,000) when
compared to the other nine antibiotics and one antibacterial
agent. Maruya et al. (2013) applied the use of Uncertainty
Factors to address the quality (inadequacies/incompleteness)
of toxicological, chemistry and microbial data in estimating
the hazards of CECs for the State of California (Anderson
et al., 2012). For antibiotic resistance, Uncertainty Factors
(10–100) were used when data for specific indicator species
were lacking (e.g., E. coli) and/or for a lack of MIC values
for both sensitive and resistant bacteria were not available.
The only antibiotic/antibacterial agent that had excessive risk
was Triclosan, which had a MEC/NOEC ratio > 1 when an
Uncertainty Factor of 10 was used. Triclosan was one of 12 new
CECs recommended for monitoring by the state of California
and the only antibiotic/antimicrobial agent recommended for
further monitoring of CECs (Anderson et al., 2012). This
combination of approaches using MECs, MICs, and Uncertainty
Factors seems to provide a path forward for assessing the
risks of antibiotics and antibacterial agents, as antibacterial
resistance research and better monitoring studies measuring
antibiotics/antibacterial agents and antibiotic resistant bacteria
continues to help us better define and understand the
complexities of antibiotic resistance within aquatic environments
and coastal ecosystems.
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